Chen Z, Jin ZX, Cai J, Li R, Deng KQ, Ji YX, et al. Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy. J Mol Med (Berl). 2022;100(12):1721–39.

Article  CAS  PubMed  Google Scholar 

Schiattarella GG, Altamirano F, Tong D, French KM, Villalobos E, Kim SY, et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature. 2019;568(7752):351–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol. 2016;594(8):2061–73.

Article  CAS  PubMed  Google Scholar 

Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH, et al. The global burden of metabolic disease: data from 2000 to 2019. Cell Metab. 2023;35(3):414-428.e413.

Article  CAS  PubMed  Google Scholar 

Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc Res. 2017;113(4):389–98.

Article  CAS  PubMed  Google Scholar 

McHugh K, DeVore AD, Wu J, Matsouaka RA, Fonarow GC, Heidenreich PA, et al. Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(5):602–11.

Article  PubMed  Google Scholar 

Suffee N, Baptista E, Piquereau J, Ponnaiah M, Doisne N, Ichou F, et al. Impacts of a high-fat diet on the metabolic profile and the phenotype of atrial myocardium in mice. Cardiovasc Res. 2022;118(15):3126–39.

Article  CAS  PubMed  Google Scholar 

Costantino S, Akhmedov A, Melina G, Mohammed SA, Othman A, Ambrosini S, et al. Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy. Eur Heart J. 2019;40(12):997–1008.

Article  CAS  PubMed  Google Scholar 

Karbasforooshan H, Karimi G. The role of SIRT1 in diabetic cardiomyopathy. Biomed Pharmacother. 2017;90:386–92.

Article  CAS  PubMed  Google Scholar 

Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy. Circ Res. 2018;122(4):624–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585–607.

Article  PubMed  PubMed Central  Google Scholar 

Kane AE, Sinclair DA. Sirtuins and NAD + in the development and treatment of metabolic and cardiovascular diseases. Circ Res. 2018. https://doi.org/10.1161/CIRCRESAHA.118.312498.

Article  PubMed  PubMed Central  Google Scholar 

Mengozzi A, Costantino S, Paneni F, Duranti E, Nannipieri M, Mancini R, et al. Targeting SIRT1 rescues age- and obesity-induced microvascular dysfunction in ex-vivo human vessels. Circ Res. 2022;131(6):476–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Winnik S, Auwerx J, Sinclair DA, Matter CM. Protective effects of sirtuins in cardiovascular diseases: from bench to bedside. Eur Heart J. 2015;36(48):3404–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang F, Kume S, Koya D. SIRT1 and insulin resistance. Nat Rev Endocrinol. 2009;5(7):367–73.

Article  CAS  PubMed  Google Scholar 

Li Y, Wong K, Giles A, Jiang J, Lee JW, Adams AC, et al. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology. 2014;146(2):539-549.e537.

Article  CAS  PubMed  Google Scholar 

Yamamoto T, Sano M. Deranged myocardial fatty acid metabolism in heart failure. Int J Mol Sci. 2022;23(2):996.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263–71.

Article  PubMed  Google Scholar 

Packer M. Cardioprotective effects of sirtuin-1 and its downstream effectors: potential role in mediating the heart failure benefits of SGLT2 (Sodium-Glucose Cotransporter 2) inhibitors. Circ Heart Fail. 2020;13(9): e007197.

Article  CAS  PubMed  Google Scholar 

Wang YJ, Paneni F, Stein S, Matter CM. Modulating sirtuin biology and nicotinamide adenine diphosphate metabolism in cardiovascular disease-from bench to bedside. Front Physiol. 2021;12:755060.

Article  PubMed  PubMed Central  Google Scholar 

Jalgaonkar MP, Parmar UM, Kulkarni YA, Oza MJ. SIRT1-FOXOs activity regulates diabetic complications. Pharmacol Res. 2022;175: 106014.

Article  CAS  PubMed  Google Scholar 

Paneni F, Costantino S, Castello L, Battista R, Capretti G, Chiandotto S, et al. Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes. Eur Heart J. 2015;36(13):817–28.

Article  CAS  PubMed  Google Scholar 

Pellegrino RM, Di Veroli A, Valeri A, Goracci L, Cruciani G. LC/MS lipid profiling from human serum: a new method for global lipid extraction. Anal Bioanal Chem. 2014;406(30):7937–48.

Article  CAS  PubMed  Google Scholar 

Narvaez-Rivas M, Zhang Q. Comprehensive untargeted lipidomic analysis using core-shell C30 particle column and high field orbitrap mass spectrometer. J Chromatogr A. 2016;1440:123–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Classification and Diagnosis of Diabetes. Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13-s27.

Google Scholar 

Yadav SK, Kambis TN, Kar S, Park SY, Mishra PK. MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro. Cell Death Dis. 2020;11(3):186.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Gu H, Li W, Lin Y, Yao X, Luo W, et al. SRC-3 knockout attenuates myocardial injury induced by chronic intermittent hypoxia in mice. Oxid Med Cell Longev. 2021;2021:6372430.

Article  PubMed  PubMed Central  Google Scholar 

Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, et al. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell. 2012;150(3):620–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wenzl FA, Ambrosini S, Mohammed SA, Kraler S, Lüscher TF, Costantino S, et al. Inflammation in metabolic cardiomyopathy. Front Cardiovasc Med. 2021;8: 742178.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peterson LR, Gropler RJ. Metabolic and molecular imaging of the diabetic cardiomyopathy. Circ Res. 2020;126(11):1628–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schiattarella GG, Rodolico D, Hill JA. Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovasc Res. 2020. https://doi.org/10.1093/cvr/cvaa217.

Article  PubMed Central  Google Scholar 

Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol. 2023;81(18):1810–34.

Article  PubMed  Google Scholar 

Gorski PA, Jang SP, Jeong D, Lee A, Lee P, Oh JG, et al. Role of SIRT1 in modulating acetylation of the sarco-endoplasmic reticulum Ca(2+)-ATPase in heart failure. Circ Res. 2019;124(9):e63–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Planavila A, Dominguez E, Navarro M, Vinciguerra M, Iglesias R, Giralt M, et al. Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart. J Mol Cell Cardiol. 2012;53(4):521–31.

Article  CAS  PubMed  Google Scholar 

Vilella R, Izzo S, Naponelli V, Savi M, Bocchi L, Dallabona C, et al. In vivo treatment with a standardized green tea extract restores cardiomyocyte contractility in diabetic rats by improving mitochondrial function through SIRT1 activation. Pharmaceuticals (Basel). 2022. https://doi.org/10.3390/ph15111337.

Article  PubMed  PubMed Central  Google Scholar 

Ren BC, Zhang YF, Liu SS, Cheng XJ, Yang X, Cui XG, et al. Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways. J Cell Mol Med. 2020;24(21):12355–67.

Article